Methylene blue
0,00 €
| Language of origin | |
|---|---|
| Publication date | |
| Rights Sold |
The blue revolution against cancer. depression and brain diseases
At a time when major pharmaceutical companies are competing fiercely to develop ever more high-tech and expensive cancer drugs, an unlikely hero is emerging from the depths of medical history: methylene blue.
Dr Schwartz, a physician and researcher, reveals the fascinating history and promise of this forgotten drug. From its first uses as a dye to its applications against infectious diseases, the story of methylene blue suggests that it could play a key role in the fight against cancer.
Cancer is a metabolic disease and methylene blue has the power to normalise this metabolism. In combination with other agents, methylene blue has already helped many patients. It could also help people suffering from Alzheimer’s, Parkinson’s and other brain diseases.
Drawing on case studies, patient testimonies and the latest advances in clinical research, Dr Schwartz paints a picture of a future in which cancer could become a common chronic disease. He calls for rapid clinical trials in the interests of patients.
Join him on this fascinating journey through science, history and medicine, and discover how the past offers hope for new victories in the fight against cancer.
Mel Gibson is Joe Rogan’s guest. His podcast, The Joe Rogan Experience (JRE), is one of the most popular in the United States (and therefore in the world).
In this video Mel Gibson testifies:
https://x.com/informeorwell/status/1877892938539139097?s=48&t=6qv4zb1O91Ot3i0HUNDRzA
Related products
